Elizabeth Lowe
Associate Director, Consumer Safety Science @Haleon
Signup · Get unlimited contacts
WORK HISTORY
Associate Director, Consumer Safety Science @Haleon
London, GB
Identification and evaluation of safety signals Define safety strategy and provide safety inputs into R&D innovation projects (e.g, safety assessments of active ingredients for front end ideation concepts and their probability of success, briefing books for Scientific Advice Meetings with the MHRA, evaluate candidates for Rx-to-OTC switch applications (Rx to P, and P to GSL reclassification). Communication of safety information to consumers/healthcare professionals (e.g, throughproduct labelling, educational materials, DHCP letters etc.) Responding to safety-related regulatory enquiries and safety referrals Monitoring post-approval safety commitments (e.g, post-authorisation safety studies) Preparing Aggregate/Periodic Safety Reports for regulatory bodies (e.g, PBRERs, MedicalDevice PMS Reports/PSURs, Cosmetic UERs etc.). Developing and maintaining product Risk Management Plans Evaluation of safety issues related to product quality/manufacturing defects (PIRC) Supporting the preparation/maintenance of eCTD Clinical Modules (e.g, Clinical Overview(incl. Addenda), Summary of Clinical Safety) Supporting the preparation/maintenance of risk management documentation in the MDTF(e.g, PMS Plan, Clinical Evaluation Plan and Report, PMCF Plan and Report etc.).
EDUCATION
University of Cambridge
Master of Philosophy (MPhil), Pharmacology
King's College London
MSc, Neuroscience
Harvard Medical School
Neuroscience
King's College London
Bachelor of Science (BSc Hons), Pharmacology
ABOUT ELIZABETH LOWE
Proven ability to lead global safety strategy, deliver compliant safety governance, and drive benefit-risk evaluation in cross-functional settings. Adept at signal management, inspection readiness, regulatory interaction, and scientific decision-making. Demonstrated capability in mentoring junior scientists and stepping into strategic leadership roles.European first -Authored the application and pharmacy guides for intranasal fluticasone propionate for 12 years and over. Press release: European first as MHRA approves over-the-counter allergy treatment for adolescents aged 12 and over - GOV.UK
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.